LNTH · NASDAQ · Drug Manufacturers - Specialty & Generic

Lantheus (LNTH)

Commercializes PET radiodiagnostics and ultrasound-enhancing agents for prostate cancer, amyloid, and cardiac imaging.

$99.92
vs last close−0.08 (−0.08%)